乳腺癌和黑色素瘤细胞系中ERK1和ERK2的相互依赖性和差异表达
Shuvojit Moulik1, Sayantani Karmakar2, Asmita Basu3
1Research and Development Wing, Suraksha Diagnostics Pvt. Ltd., Newtown, Kolkata, West Bengal, India. shuvojitmoulik@gmail.com.
Journal of the Egyptian National Cancer Institute
|September 15, 2024
概括
细胞外信号调节激酶 (ERK1和ERK2) 在癌症进展中表现出相互依赖. ERK2可以补偿ERK1的损失,而ERK1在癌细胞的侵入性中起着关键作用.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 细胞外信号调节激酶 (ERK1和ERK2) 对细胞过程至关重要.
- 这些由MAPK3和MAPK1编码的异构体在癌症中表现出差异性表达和相互依赖.
- 之前的工作突出了它们对参与细胞生长和分化的细胞外分子的影响.
研究的目的:
- 研究ERK1和ERK2.2的个别作用.
- 确定它们在癌细胞进展和侵入性方面的相互依赖性.
主要方法:
- 使用了黑色素瘤 (B16F10) 和乳腺癌 (MCF7,MDAMB231) 细胞系.
- 采用了包括siRNA转染,西式涂抹和细胞入侵测试在内的技术.
主要成果:
- 通过ERK1.1,观察到ERK2缺陷的补偿.
- 在MCF7细胞中确定了ERK2的主导地位.
- 在MDAMB231细胞中证明了ERK1-ERK2的相互依赖性.
- 证实了这两种激酶在调节MMP9中的重要作用.
结论:
- ERK1和ERK2表现出相互补偿.
- ERK1在癌细胞侵入性方面发挥着重要作用.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


